shahin mohammed
@shahsonride.bsky.social
Nephrologist. Dad. NSMC intern class of 2024. Here for ultrafiltration.
Register NOW for #ISNCON25 ✅ Conference Registration isncon2025lucknow.com/registration ✅ Workshop Registration www.isncon2025.com/workshop-registration Pre-Conf Workshop -Critical Care Nephrology & POCUS -18th Dec 2025 📌 Free Registration for the Workshop! (But you must register for the Conference)
Check out the VA from @drsaivani.bsky.social and @nephromommy-akshu.bsky.social on eGFRdiff in the CRIC cohort. #Nephsky #NephJC www.nephjc.com/news/cricdiff
Insights from the CRIC Study: Visual Abstract — NephJC
Based on data from the CRIC study, this analysis dives deep into whether this lab mismatch is just noise… or a clinical signal we’ve been missing. Check out the beautiful visual abstract made by our NephJC interns Sai Vani Yellampalli and Akshaya Jayachandran . Great team work!!!
nephjc.com
We are nephrologists. Hyperkalemia is what scares endocrinologist and cardiologists. we have the knowledge and the tools to manage this problem in this era when using the combo #NephJC
🆕 #NephJCshort by @hswapnil.medsky.social on CARDIA SSBP trial @jama.com 🧂Shaking up an old rule: does less salt still mean less pressure? #medsky #nephsky www.nephjc.com/news/2025/6/...
NephJC Shorts: Salt reduction still lowers BP — NephJC
JAMA 2023 Dec 19;330(23):2258-2266 doi: 10.1001/jama.2023.23651. Effect of Dietary Sodium on Blood Pressure: A Crossover Trial Deepak K Gupta , Cora E Lewis , Krista A Varady , ...
nephjc.com
🎨Check out the beautiful #visualabstract by #NephJC intern @shelliefravel.bsky.social ⏰Chat happening on July 8, 9 pm EST www.nephjc.com/news/2025/7/...
CONFIDENCE Visual Abstract — NephJC
Check out the beautiful visual abstract made by NephJC intern Michelle Fravel .
nephjc.com
With unshakable CONFIDENCE, finerenone and empagliflozin waltz into diabetic kidney disease - turning 'maybe someday' into 'why not today?' #NephJC summary by @sejalplakhani.bsky.social and @jeyakumarmeyyappan.bsky.social #MedSky www.nephjc.com/news/confide...
A dose of CONFIDENCE: Building evidence for finerenone-empagliflozin synergy in diabetic kidney disease — NephJC
This week, we will discuss how the CONFIDENCE trial gets nephrology closer to the magic CKD polypill of CKD.
nephjc.com
🔥 BKV Infection in Kidney Transplant Recipients- A major threat to graft survival! 🎤 Don’t miss this exclusive webinar by @isn-india.bsky.social & @ttsorg.bsky.social featuring international experts🌍 🗓 8th May 2025 ⏰ 7:30 PM IST 🔗 Register now: tinyurl.com/sueuuth6 @arvindcanchi.bsky.social
🎤#ISNCON2025 Preconference workshops : 🗓️18 Dec | Top faculty 🌏 🔹Intervention Nephrology 🔹Critical Care + POCUS 🔹Onconephro & Histopath 🔹Pediatric Nephrology 👶 🔹Transplant Immunology ✅ Free for delegates ⏳ Limited seats! Hurry! ➡️ 🔗 isn-india.org/isn_registrati… @isn-india.bsky.social
✨ #ISNCON2025 Lucknow Awaits! 🎖️India's Premier #Nephrology Event by @isn-india.bsky.social 🤞🏽Learn ∙ 🤝 Connect ∙ 🌟 Grow 📢 Early bird discounts (Hurry!) 🎓 50% off for students 🔗 Register now: isn-india.org/isn_registrati… @arvindcanchi.bsky.social @kajareeg.bsky.social @jasminenephro.bsky.social
🚨 Don’t miss out! 🎤 Present your work at @isn-india.bsky.social ’s flagship #ISNCON2025 in Lucknow! ✨ 📢 Abstracts accepted now→ Published in 📖 IJN Publications. 🔗 Submit here 👉 isn-india.org/isn_registra... @arvindcanchi.bsky.social @kajareeg.bsky.social @jasminenephro.bsky.social
Hey #NephSky & #MedSky 9pm EST 4/15/25, only on #Bluesky Discussion on the use of metformin in advanced CKD. Worried about lactic acidosis 💪?! What's the evidence that an eGFR < 30 ml/min is the ideal cutoff ✂️? Are there benefits to continuing 💊 www.nephjc.com/news/metformin-tte
Metformin- Should I Stay or Should I Go — NephJC
This week, we will discuss another target trial emulation study. The FDA says to stop metformin at a GFR of 30. Are they right?
nephjc.com
Not all cystic kidneys = ADPKD! Inherited & acquired mimics exist. Don’t miss infographic by @drpallaviprasad.bsky.social! #NephJC
Happening this week! The @kdigo.org guidelines in #ADPKD #PKD on #NephJC www.nephjc.com/news/adpkd-k... Summary from @brianrifkin.bsky.social
KDIGO 2025 ADPKD Guidelines Review — NephJC
This week, we will discuss the first iteration of KDIGO’s 2025 guidelines on ADPKD. These guidelines are a result of a decade of global collaboration between physicians, researchers, advocates, ...
nephjc.com
Added an addendum to this chapter: www.rosebook.club/blog/2025/3/...
Chapter 18 addendum — Channel Your Enthusiasm
After publishing chapter 18 part 1, I was listening to it and realized we missed an opportunity to clarify something that was vexing Rose. He said that the mechanism by which bicarbonate reabsorption ...
rosebook.club
Joel Topf@kidneyboy.bsky.social · last yr.Just posted the latest episode of Channel Your Enthusiasm. This brings halfway through chapter 18. There is a raging debate over contraction alkalosis and by the end Melanie throughly routs Roger's impassioned defense of good ol' fashion contraction! www.rosebook.club/episodes/202...
We are discussing the @kdigo.org ADPKD guidelines tomorrow on #NephJC Perfect timing for @jama.com to drop this review jamanetwork.com/journals/jam... ($ub required sadly 🔒) #NephSky
A Review of Autosomal Dominant Polycystic Kidney Disease
This review discusses the pathophysiology, clinical presentation, diagnosis, treatment, and prognosis of autosomal dominant polycystic kidney disease diagnosed in adulthood.
jamanetwork.com
This one www.nejm.org/doi/full/10.... #NephJc
A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy | NEJM
A proliferation-inducing ligand (APRIL) is implicated in the pathogenesis of IgA nephropathy. Sibeprenlimab is a humanized IgG2 monoclonal antibody that binds to and neutralizes APRIL. In this phas...
nejm.org
Aha! And here's a bit about that trial (Regency/Obinutuzumab) from the one of the lead authors Dr Brad Rovin ( he's not on @bsky.app yet 🤔) #nephjc youtu.be/DnMnTpCbFQY
WCN'25 interview with Brad Rovin by Arvind Canchi
YouTube video by International Society of Nephrology
youtu.be
This week (and tonight on #NephJC) we are discussing the REGENCY trial on #obinutuzumab in SLE specifically #lupus nephritis summary from @sayalibthakare.bsky.social @dramiliflores.bsky.social & @nephroseeker.medsky.social www.nephjc.com/news/regency... #lupuschat #NephSky #RheumSky
Obinutuzumab in Lupus Nephritis — NephJC
This week, we will celebrate in advance World Kidney Day by discussing the results of OBInutuzumab in active lupus nephritis. The LUNAR trial (rituximab versus placebo) was “almost” positive, but not ...
nephjc.com
👋See you tonight (😉hope you've read the supplement) #nephjc ⏰ 9 pm EST as always 🔔For people outside North America, be mindful of timezone difference (daylight savings)
Swapnil Hiremath 🍁🇨🇦@hswapnil.medsky.social · last yr.This week (and tonight on #NephJC) we are discussing the REGENCY trial on #obinutuzumab in SLE specifically #lupus nephritis summary from @sayalibthakare.bsky.social @dramiliflores.bsky.social & @nephroseeker.medsky.social www.nephjc.com/news/regency... #lupuschat #NephSky #RheumSky
1/10 Last #NephJC we continued our Aldo streak as we discussed mineralocorticoid antagonist (MRA) withdrawal before ✅aldosterone renin ratio (ARR) & adrenal vein sampling (AVS) #NephSky #MedSky #TenPostNephJC makes this #Endosky oriented topic easy. pubmed.ncbi.nlm.nih.gov/39660429/
It's March, 2 days before #WorldKidneyDay, so tonight there is the perfect opportunity to celebrate ( 9 pm Eastern, on 🦋)🌺🌻 #NephJC 🎨Until then, take a look at this beautiful and colorful #visualabstract made by Divya Bajpai www.nephjc.com/news/2025/3/...
Obinutuzumab in lupus nephritis: The REGENCY Trial Visual Abstract — NephJC
Is Obinutuzumab Effective and Safe in Active Lupus Nephritis? Check out the beautiful VA by NSMC Faculty Dr Divya Bajpai on the REGENCY Trial, answering the same.
nephjc.com
Excited to see this finally in press! Special thanks to @hswapnil.medsky.social for invitation and coauthors Abdulghani Kabli, Oleksa Rewa, Ted Clark. #canada. Special thanks to my role models Etienne Macedo and Ravi Mehta whose prior version we built upon. #nephsky #medsky #emimcc rb.gy/8kke9h
Continuous Kidney Replacement Therapies: Core Curriculum 2025
Critically ill patients that require kidney replacement therapy (KRT) are among the most ill and complex patients routinely encountered in the intensi…
sciencedirect.com
#Nephmadness: “As we dissect the molecular biology of INS, … it is a fantastic time to be a (pediatric) nephrologist.“ - @carafuentes-neph.bsky.social ajkdblog.org/2025/03/07/n...
#NephMadness 2025: Minimal Change Disease – Beyond “Idiopathic”; Redefining Nephrotic Syndrome for the Modern Era
Submit your picks! | @NephMadness | @nephmadness.bsky.social | NephMadness 2025 Gabriel Miguel Cara Fuentes @carafuentes_g – @carafuentes-neph.bsky.social Dr. Cara Fuentes is an Assistant P…
ajkdblog.org
Announcing the #NephJC internship, @nephjc.bsky.social and @kireports.bsky.social joining forces www.nephjc.com/intern-app for details and to apply! #NephSky
NephJC Editorial Internship — NephJC
nephjc.com
During March we celebrate World Kidney Day! #NephMadness it’s a great way to make all March about kidneys 🌸🌷 👇See the topics here! who do you think it will win this year? ✨Glad I could contribute ajkdblog.org/tag/nephmadn...
NephMadness2025 – AJKD Blog
Posts about NephMadness2025 written by AJKDblog
ajkdblog.org
The first #NephMadness podcast dropped. Green House thepoisonlab.com/episode/the-...
Leafy Greens & Injured Beans: Natures Nephrotoxins – A Poison Lab & NephMadness Collaboration - The Poison Lab
In this special collaboration with NephMadness, we're diving into the world of nephrotoxins with an expert panel from Virginia Commonwealth University. ...
thepoisonlab.com
ACE inhibitors are not nephrotoxic - but 🐍 snakebite from Bothrops spp can cause AKI in kids link.springer.com/article/10.1... In @ped-neph.bsky.social Though it seems not always mediated by hypotension #NephSky
Acute kidney injury induced by snakebites in pediatric patients - Pediatric Nephrology
Background Snakebites are a significant public health problem worldwide, with a global prevalence estimated 2.7 million envenomings and 81,000 to 138,000 deaths annually. Acute kidney injury (AKI) is ...
link.springer.com
HAPPENING TODAY!! Master Class *Case Presentation in Nephrology* 28 Feb 2025 Friday 8 PM IST Case- Acute Kidney Injury Moderator: Prof Vinay Sakhuja Presented by - Dr Harsh Patel, MPUH @jasminenephro.bsky.social @isn-india.bsky.social Plz register using the link in.eregnow.com/ticketing/re...
